Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT

Pyxis Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
12.76M 19.47M 12.06M 25.07M 29.44M 11.14M 14.71M 25.9M 53.06M 179.29M 198.54M 223.35M 247.09M 274.74M 133.48M 142.47M -8.08M
Short-Term Investments
92.67M 107.46M 132.76M 130.65M 129.06M 109.63M 118.25M 116.77M 96.29M n/a n/a n/a n/a n/a n/a n/a 16.16M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 449K 109K 3.61M 2.25M -8.08M
Receivables
n/a n/a n/a n/a 8M 21K n/a n/a n/a 598K n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.34M n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
6.44M 4.75M 4.05M 5.31M 1.47M 4.27M 6.13M 6.64M 1.47M 5.41M 1.47M 1.47M 1.47M 2.17M 859K n/a n/a
Total Current Assets
111.87M 132.44M 148.87M 161.04M 172.38M 124.6M 139.09M 149.3M 156.18M 186.61M 202.81M 226.59M 251.26M 278.67M 134.34M 142.94M 8.08M
Property-Plant & Equipment
21.45M 22.14M 22.82M 23.68M 24.11M 24.81M 25.3M 25.93M 26.62M 24.77M 21.09M 15.97M 995K 1.24M 1.54M 1.85M n/a
Goodwill & Intangibles
2.54M 2.6M 23.62M 23.68M 23.73M 24.31M 22.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
24M 24.74M 46.44M 47.35M 47.84M 49.12M 47.6M 25.93M 26.62M 24.77M 21.09M 15.97M 1.44M 1.35M 5.15M 4.11M -8.08M
Total Assets
135.87M 157.18M 195.31M 208.39M 220.22M 173.73M 186.69M 175.23M 182.8M 211.38M 223.9M 242.56M 252.7M 280.02M 139.49M 147.05M n/a
Account Payables
2.85M 4.86M 4.87M 5.47M 2.29M 3.9M 3.31M 1.3M 4.03M 7.1M 5.51M 7.82M 2.06M 11.95M 1.93M 1.27M n/a
Deferred Revenue
n/a n/a n/a -11.43M n/a 7.66M 7.19M n/a n/a n/a n/a n/a n/a 6.33M 5.46M 2.24M n/a
Short-Term Debt
n/a 1.45M n/a 1.34M n/a 1.23M 1.2M 527K n/a n/a n/a n/a n/a n/a 325K n/a n/a
Other Current Liabilities
n/a 7.39M n/a -1.34M n/a 6.52M -2.41M -527K n/a 1.09M n/a n/a n/a 3.63M 9.3M 4.43M n/a
Total Current Liabilities
14.43M 17.68M 20.32M 16.9M 14.14M 25.76M 28.33M 9.22M 11.6M 31.63M 19.09M 14.92M 19.19M 18.71M 16.84M 8.41M n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 194.09M 196.22M n/a
Total Long-Term Liabilities
18.33M 18.75M 21.31M 21.7M 21.92M 22.26M 20.41M 20.73M 19.04M 18.92M 16.05M 15.68M 2.06M 12.12M 194.09M 196.22M n/a
Total Liabilities
32.76M 36.43M 41.63M 38.59M 36.06M 48.02M 48.75M 29.95M 30.64M 50.55M 35.15M 30.6M 19.19M 18.71M 210.93M 204.64M n/a
Total Debt
19.84M 20.2M 20.54M 20.87M 20.78M 21.33M 21.62M 21.26M 20.25M 18.92M 16.05M 15.68M n/a 165K 325K 481K n/a
Common Stock
62K 60K 59K 59K 59K 45K 44K 39K 37K 34K 32K 32K 32K 32K 2K 2K n/a
Retained Earnings
-384.71M -363.56M -327.99M -306.78M -289.48M -286.23M -270.63M -247.58M -231.68M -212.44M -176.33M -148.66M -123.1M -91.72M -74.89M -60.71M n/a
Comprehensive Income
49K 170K 351K -102K -60K 63K -105K -85K 696K n/a 0.00 n/a 0.00 -0.00 -21.94M n/a -15.64M
Shareholders Equity
103.1M 120.75M 153.68M 169.79M 184.16M 125.7M 137.95M 145.28M 152.16M 160.82M 188.75M 211.97M 233.51M 261.31M -71.44M -57.59M 6.3M
Total Investments
92.67M 107.46M 132.76M 130.65M 129.06M 109.63M 118.25M 116.77M 96.29M n/a n/a n/a n/a n/a n/a n/a 16.16M